Directed Molecular Diagnostic Tests Highlight Recent Microbiology Conference
By LabMedica International staff writers Posted on 08 Jul 2015 |
The performance of a series of directed molecular diagnostic tests was confirmed by several studies presented at a recent microbiology conference.
Nanosphere (Northbrook, IL, USA) manufactures tests designed to target infections of the bloodstream, respiratory tract, and gastrointestinal tract. The Nanosphere Verigene System rapidly and accurately detects infectious pathogens and drug resistance markers by targeting conserved genetic regions of a bacterium or virus. These assays are based on nanoparticles that are typically 13–20 nanometers in diameter. Depending upon the application, each nanoparticle is functionalized with either a defined number of DNA or RNA oligonucleotides or a defined number of antibodies that are specific to a particular protein of interest.
Tests are conducted in the Verigene Processor SP, which is a modular, easy-to-use benchtop analyzer that combines automated nucleic acid extraction, purification, amplification, and hybridization in each module. These advanced capabilities allow users to run Verigene Tests on-demand in response to testing needs, without the need for batch processing, specially trained personnel, or specialized facilities. The associated Verigene Reader manages sample information, reads results from processed cartridges, and enables printing of results, internal data storage, and LIS (laboratory information system) connectivity without the need for an external PC. The Verigene System is scalable, allowing throughput customization to meet the size and testing demands of each laboratory.
Seven studies evaluating the performance and clinical impact of select Verigene multiplex infectious disease tests were presented at the 115th General Meeting of the American Society for Microbiology held in 2015 in New Orleans, LA, USA. Three of the studies highlighted the superior performance and broad antibiotic resistance coverage of the Verigene Gram-Negative Blood Culture Test (BC-GN). Four other studies highlighted the accuracy and utility of the Verigene Gram-Positive Blood Culture Test (BC-GP), the Verigene Enteric Pathogens Test (EP), and the research-use only Verigene Respiratory Pathogens Flex Test (RP Flex).
Related Links:
Nanosphere
Nanosphere (Northbrook, IL, USA) manufactures tests designed to target infections of the bloodstream, respiratory tract, and gastrointestinal tract. The Nanosphere Verigene System rapidly and accurately detects infectious pathogens and drug resistance markers by targeting conserved genetic regions of a bacterium or virus. These assays are based on nanoparticles that are typically 13–20 nanometers in diameter. Depending upon the application, each nanoparticle is functionalized with either a defined number of DNA or RNA oligonucleotides or a defined number of antibodies that are specific to a particular protein of interest.
Tests are conducted in the Verigene Processor SP, which is a modular, easy-to-use benchtop analyzer that combines automated nucleic acid extraction, purification, amplification, and hybridization in each module. These advanced capabilities allow users to run Verigene Tests on-demand in response to testing needs, without the need for batch processing, specially trained personnel, or specialized facilities. The associated Verigene Reader manages sample information, reads results from processed cartridges, and enables printing of results, internal data storage, and LIS (laboratory information system) connectivity without the need for an external PC. The Verigene System is scalable, allowing throughput customization to meet the size and testing demands of each laboratory.
Seven studies evaluating the performance and clinical impact of select Verigene multiplex infectious disease tests were presented at the 115th General Meeting of the American Society for Microbiology held in 2015 in New Orleans, LA, USA. Three of the studies highlighted the superior performance and broad antibiotic resistance coverage of the Verigene Gram-Negative Blood Culture Test (BC-GN). Four other studies highlighted the accuracy and utility of the Verigene Gram-Positive Blood Culture Test (BC-GP), the Verigene Enteric Pathogens Test (EP), and the research-use only Verigene Respiratory Pathogens Flex Test (RP Flex).
Related Links:
Nanosphere
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability